SEC Filing Summary: iHuman Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by iHuman Inc., a foreign private issuer headquartered in Beijing, China, for the month of June 2025. The report was signed on June 26, 2025, by Vivien Weiwei Wang, Director and Chief Financial Officer. The filing serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing text does not provide information regarding material changes versus the prior comparable period.
Guidance, Outlook, and Risks
The filing includes an exhibit index referencing a Press Release (Exhibit 99.1) but does not contain the text of the press release itself. Consequently, there is no management commentary, guidance, outlook, risk disclosure, or description of unusual items within the provided content.
Key Facts for Investor Verification
- Verify the content of the referenced Press Release (Exhibit 99.1) to understand the specific event triggering this filing.
- Confirm the company's current financial status through its most recent Form 20-F or quarterly reports, as this 6-K contains no financial metrics.
- Note the filing date of June 26, 2025, and the signatory authority of the CFO.